When was GeneInsight founded?

GeneInsight was founded in 2012.

Where is GeneInsight located?

GeneInsight is headquartered in Boston, United States.

Is GeneInsight a funded company?

GeneInsight is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round.

When was the latest funding round of GeneInsight?

GeneInsight's latest funding was a $***** PE round on Sep 18, 2014, with participation from 1 investor. Its primary sector is Genomics. In United States, the Genomics sector has seen $1.84B in funding in 2026 to date.

Where does GeneInsight rank among its competitors?

GeneInsight ranks 586th amongst 888 active competitors, of which 155 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was SeqOne, which secured $22.7M in May, 2025.

Who are the top competitors of GeneInsight?

GeneInsight's top competitors include Benchling, Helix and Congenica. Among them, SeqOne secured the most recent funding round in May, 2025.

GeneInsight - 2026 Company Profile, Funding & Competitors

Company Details

GeneInsight is a platform developed by Partners Healthcare and used to streamline the analytics, interpretation and reporting of genetic test results. GeneInsight supports the interpretation and reporting of genetic sequencing and the delivery of results to clinicians. Solutions include: GeneInsight Lab, a laboratory tool to assist with knowledge management and report generation; GeneInsight Clinic, a standalone clinician interface to enable delivery of patient genetic test results to clinicians; GeneInsight Network, a networking infrastructure designed to enable transfer of structured genetic data between and among laboratories and clinicians.

Website: geneinsight.com
Social
Part Of

Key Metrics

Founded Year

2012

Location

Boston, United States

Stage

Acqui-Hired

Latest Funding Round

PE, Sep 18, 2014, $*****

Investors

NIH & 1 more

Ranked

586^th among 888 active competitors

Similar Companies

Benchling & 1158 more

View GeneInsight's full profile

GeneInsight has raised funding over 2 rounds. Its latest funding round was a PE round on Sep 18, 2014 for $*****. 1 investor participated in its latest round. GeneInsight has 2 institutional investors.

Here is the list of recent funding rounds of GeneInsight:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 18, 2014	3920769	PE	9028354	1261461	3861061	2380271

Access funding benchmarks and valuations. Sign up today!

View details of GeneInsight's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of GeneInsight include Benchling, Helix and Congenica. Here is the list of Top 10 competitors of GeneInsight, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Benchling 2012, San Francisco (United States), Series F	Provider of a cloud-based bioinformatics platform for biotech research	$412M	Altimeter Capital, Benchmark & 28 others	73/100
2nd	Helix 2015, San Francisco (United States), Series E	Provider of a genomic database for clinical research	$435M	DFJ Growth, Kleiner Perkins & 12 others	71/100
3rd	Congenica 2013, Cambridge (United Kingdom), Acquired	Developer of software for clinical genomic interpretation and variant analysis	$81.9M	IDO Investments, Xeraya Capital & 39 others	62/100
4th	Deep Genomics 2014, Toronto (Canada), Series C	AI-powered platform for RNA biology to accelerate genetic therapy discovery	$238M	SoftBank Vision Fund, True Ventures & 16 others	62/100
5th	Sophia Genetics 2011, Rolle (Switzerland), Public	Provider of artificial intelligence software for analyzing complex medical data	$249M	Generation Investment Management, Endeavour Vision ... & 24 others	62/100
6th	Hexagon Bio 2017, Menlo Park (United States), Series B	Provider of bioinformatics tools for the analysis of microbial genomic sequencing data	$206M	The Column Group, Nextech Invest & 10 others	62/100
7th	Latch 2021, San Francisco (United States), Series A	Provider of a web-based platform for genomic bioinformatics	$33M	Lux Capital, Coatue & 7 others	59/100
8th	BC Platforms 1997, Zurich (Switzerland), Series D	Provider of a platforms for genomic data analysis and management	$47.1M	Jolt Capital, Debiopharm & 6 others	58/100
9th	SeqOne 2017, Montpellier (France), Series A	Provider of bioinformatics tools for the analysis of genome sequencing data	$48.8M	Elaia, Omnes Capital & 7 others	57/100
10th	BostonGene 2015, Waltham (United States), Series B	Developer of cloud-based information and analytics platform to treat cancer	$200M	NEC, Japan Industrial Partners & 1 others	57/100
586th	GeneInsight 2012, Boston (United States), Acqui-Hired	Platform for genetic data analysis, interpretation and reporting	-	NIH, Sunquest Information Systems	22/100